Do drugs have a place in the treatment of eating disorders in adolescence?

References

• Råstam M, Gillberg C, Garton M. Anorexia nervosa in a Swedish urban region. A population-based study. Br J Psychiatry 1989; 155: 642–46
   PubMed Web of Science ®Google Scholar
• Crisp A H, Toms D A. Primary anorexia nervosa or weight phobia in the male: report on 13 cases. Br Med J 1972; i: 344–8
   Google Scholar
• Fairburn C F, Beglin S J. Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 1990; 147: 401–8
   PubMed Web of Science ®Google Scholar
• Flament M F, Ledoux S, Jeammet P, . A population study of bulimia nervosa and subclinical eating disorders in adolescence. Eating disorders in adolescence, H C Steinhausen, et al. de Gruyter, Berlin/New York 1995
   Google Scholar
• Steinhausen H C, Neumärker K J, Boyadjieva S. Transcultural comparisons of adolescent eating disorders. Eating disorders in adolescence, H C Steinhausen. de Gruyter, Berlin/New York. 1995; 37–46
   Google Scholar
• Dally P J, Sargant W. A new treatment of anorexia nervosa. Br Med J 1960; i: 1770–3
   Google Scholar
• Gillberg C, Råstam M, Gillberg I C. Anorexia nervosa: who sees the patients and who do the patients see?. Acta Paediatr 1994; 83: 967–71
   PubMedGoogle Scholar
• Lennkh C, De Zwaan M, Kasper S. New aspects of diagnosis and phannacotherapy of eating disorders. Int J Psychiatr Clin Practice 1997; 1: 21–35
   PubMedGoogle Scholar
• Biederman J, Herzog D B, Rivinus T M, et al. Amytriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. J Clin Psychopharmacol 1985; 5: 10–16
   PubMed Web of Science ®Google Scholar
• Halmi K A, Eckert E, La Du T J, Cohen J. Anorexia nervosa: Treatment efficacy of cyproheptadine and amytriptyline. Arch Gen Psychiatry 1986; 43: 177–81
   PubMed Web of Science ®Google Scholar
• Lacey J H, Crisp A H. Hunger, food intake and weight: The impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 1980; 56(Suppl 1)79–85
   PubMedGoogle Scholar
• Pope H G, Hudson J I, Jonas J M, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled double-blind study. Am J Psychiatry 1983; 140: 554–60
   PubMed Web of Science ®Google Scholar
• Mitchell J E, Groat R. A placebo-controlled, double-blind crossover trial of amitriptyline in bulimia nervosa. J Clin Psychopharmacol 1984; 4: 186–93
   PubMed Web of Science ®Google Scholar
• Hughes P L, Wells L A, Cunningham C J, Ilstrup D M. Treating bulimia with desipramine. Arch Gen Psychiatry 1986; 43: 182–6
   PubMed Web of Science ®Google Scholar
• Agras W S, Dorian B, Kirkely B G, et al. Imipramine in the treatment of bulimia: A double-blind controlled study. Int J Eating Dis 1987; 6: 29–38
   Web of Science ®Google Scholar
• Barlow J, Blouin J, Blouin A, Perez E. Treatment of bulimia with desipramine: A double-blind crossover study. Can J Psychiatry 1988; 33: 129–33
   PubMed Web of Science ®Google Scholar
• Blouin A G, Blouin J H, Perez E L, et al. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988; 8: 261–9
   PubMed Web of Science ®Google Scholar
• Mitchell J E, Pyle R L, Eckert E D, et al. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990; 47: 149–57
   PubMed Web of Science ®Google Scholar
• Walsh B T, Hagidan C M, Devlin M J, et al. Long-term treatment outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991; 148: 1206–12
   PubMed Web of Science ®Google Scholar
• Agras W S, Rossiter E M, Arnow B, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. Am J Pscyhiatry 1992; 149: 82–7
   PubMed Web of Science ®Google Scholar
• Liebowitz S F, Weiss F G, Shor-Posner G. Medical hypothalamic serotonin in the control of eating behavior. Int J Obesity 1985; 11(Suppl 3)110–23
   Google Scholar
• åkefeldt A, Lekman A, Lindblad B, et al. Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biological Psychiatry 1997, Submitted.
   Google Scholar
• Kaye W H, Weltzin T E, Hsu L KG, Bulik C M. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991; 52: 464–71
   PubMed Web of Science ®Google Scholar
• Fichter M M, Leibl K, Rief W, et al. Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24: 1–7
   PubMed Web of Science ®Google Scholar
• Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. Arch Gen Psychiatry 1992; 49: 139–47
   PubMed Web of Science ®Google Scholar
• Gardiner H M, Freeman C PL, Jesinger D K, Collins S A. Fluoxamine: An open pilot study in moderately obese female patient suffering from atypical eating disorders and episodes of bingeing. Int J Obes Relat Metab Disord 1993; 17: 301–5
   PubMedGoogle Scholar
• Robinson P H, Checkley S A, Russell G FM. Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychiatry 1985; 146: 169–76
   PubMed Web of Science ®Google Scholar
• Walsh T B. Phannacotherapy of eating disorders. Eating disorders and obesity, K D Brownell, C G Fairburn. Guilford Press, New York. 1995; 313–7
   Google Scholar
• Kennedy S H, Piran N, Warsch J J, et al. A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 1988; 8: 391–6
   PubMed Web of Science ®Google Scholar
• Walsh B T, Stewart J W, Roose S P, et al. A double-blind trial of phenelzine in bulimia. J Psychiatr Res 1985; 19: 485–9
   PubMedGoogle Scholar
• Gross H A, Ebert E D, Halmi K, et al. A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1981; 11: 376–81
   Google Scholar
• Hsu L KG, Clement L, Santhouse R. Treatment of bulimia with lithium: a preliminary study. Psychopharmacol Bull 1987; 23: 45–8
   PubMedGoogle Scholar
• Vigersky R A, Loriaux D L. The effect of cyproheptadine in anorexia nervosa: A double-blind trial. Anorexia nervosa, R A Vigersky. Raven Press, New York 1977; 349–56
   Google Scholar
• Goldberg S C, Halmi K A, Eckert E D, et al. Cyproheptadine in anorexia nervosa. Br J Psychiatry 1979; 134: 67–70
   PubMed Web of Science ®Google Scholar
• Goldberg S C, Eckert E D, Halmi K A, et al. Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. Arch Gen Psychiatry 1980; 37: 1083
   PubMed Web of Science ®Google Scholar
• Halmi K A, Eckert E D, Falk J R. Cyproheptadine, an antidepressant and weight-inducing drug for anorexia nervosa. Psychopharmacol Bull 1983; 1: 103–5
   Google Scholar
• Heebink D M, Halmi K A. Psychopharmacology in adolescents with eating disorders. Eating disorders in adolescence, H C Steinhausen. de Gruyter, Berlin/New York. 1995; 271–285
   Google Scholar
• Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled crossover study. Acta Psychiatr Scand 1982; 66: 445–50
   PubMed Web of Science ®Google Scholar
• Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984; 144: 288–92
   PubMed Web of Science ®Google Scholar
• Wermuth B M, Davis K L, Hollister L E, Stunkard A J. Phenytoin treatment of the binge-eating syndrome. Am J Psychiatry 1977; 134: 1249–53
   PubMed Web of Science ®Google Scholar
• Russell G FM, Checkley S A, Feldman J, Eisler I. A controlled trial of d-fenfluramine in bulimia nervosa. Clin Neuropharmacol 1988; 11(Suppl 1)S146–S149
   Google Scholar
• Fahy T A, Eisler I, Russell G F. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993; 162: 597–603
   PubMed Web of Science ®Google Scholar
• Mitchell J E, Christenson G, Jennings J, et al. A placebo controlled double blind crossover study of naltrexone hydro-chloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 1989; 9: 94–7
   PubMed Web of Science ®Google Scholar
• Alger S A, Schwalberg M D, Bigaouette J M, et al. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutrition 1991; 53: 865–71
   PubMed Web of Science ®Google Scholar
• Birmingham C L, Goldner E M, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eating Dis 1994; 15: 251–5
   PubMed Web of Science ®Google Scholar
• Goldstein D J, Wilson M G, Thompson V L, et al. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry 1995; 166(5)660–6
   PubMedGoogle Scholar
• Fichter M M, Kruger R, Rief W, et al. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psycho-pharmocol 1996; 16: 9–18
   PubMed Web of Science ®Google Scholar
• Walsh B T, Wilson G T, Loeb K L, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997; 154: 523–31
   PubMed Web of Science ®Google Scholar
• Sznmkler G IY, Miller G, Lichtenstein M, Binns D S. A controlled trial of cisapride in anorexia nervosa. Int J Eating Dis 1995; 17: 347–57
   PubMedGoogle Scholar
• Stunkard A, Berkowitz R, Tanrikut C, et al. d-fenfluramine treatment of binge eating disorder. Am J Psychiatry 1996; 153: 1455–9
   PubMed Web of Science ®Google Scholar